• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Med . Electronic nudges for sustained influenza vaccination uptake in older adults: the nationwide randomized NUDGE-FLU-2 trial

tetano

Editor, Senior Moderator
Nat Med


. 2024 Aug 30.
doi: 10.1038/s41591-024-03202-4. Online ahead of print. Electronic nudges for sustained influenza vaccination uptake in older adults: the nationwide randomized NUDGE-FLU-2 trial

Niklas Dyrby Johansen[SUP] 1 2 3 [/SUP], Muthiah Vaduganathan[SUP] 3 4 [/SUP], Ankeet S Bhatt[SUP] 4 5 6 [/SUP], Daniel Modin[SUP] 1 2 [/SUP], Safia Chatur[SUP] 3 [/SUP], Brian L Claggett[SUP] 3 [/SUP], Kira Hyldekær Janstrup[SUP] 1 2 [/SUP], Carsten Schade Larsen[SUP] 7 [/SUP], Lykke Larsen[SUP] 8 [/SUP], Lothar Wiese[SUP] 9 [/SUP], Michael Dalager-Pedersen[SUP] 10 11 [/SUP], Lars Køber[SUP] 12 13 [/SUP], Scott D Solomon[SUP] 3 [/SUP], Pradeesh Sivapalan[SUP] 12 14 [/SUP], Jens Ulrik Stæhr Jensen[SUP] 12 14 [/SUP], Cyril Jean-Marie Martel[SUP] 15 [/SUP], Tyra Grove Krause[SUP] 15 [/SUP], Tor Biering-Sørensen[SUP] 16 17 18 [/SUP]



Affiliations
Abstract

Digital letter interventions have proven effective in increasing influenza vaccination rates. In this trial, we sought to further refine these strategies and investigated whether the effectiveness of the strategies could be sustained across consecutive influenza seasons. We enrolled all eligible Danish citizens 65 years of age or older in a nationwide registry-based randomized implementation trial during the 2023-2024 influenza season. Households of participants were randomly assigned in a 2.45:1:1:1:1:1:1 ratio to usual care or six different behaviorally informed electronic letter-based nudges delivered before the influenza vaccination period. The primary endpoint was receipt of influenza vaccination. Statistical analyses accounted for household-level clustering. A total of 881,373 participants (mean age 74.1 ± 6.5 years, 52.1% female) were randomized across 649,487 households. The primary endpoint was met; influenza vaccination rates were higher in the pooled intervention letter group compared to usual care (76.32% versus 76.02%; difference, 0.31 percentage points; 99.29% confidence interval, 0.00-0.61; P = 0.007). Although no individual letter significantly increased influenza vaccination rates, the directionality of effect was consistent across all letters. Effectiveness was particularly pronounced in participants who had not received influenza vaccination during the preceding season (P[SUB]interaction[/SUB] = 0.010). Effectiveness was consistent regardless of whether participants had received a similar electronic letter-based nudge in the preceding season (P[SUB]interaction[/SUB] = 0.26). In summary, electronic letter-based nudges successfully increased influenza vaccination among older adults, and our results suggest that these highly scalable strategies can be implemented effectively and safely across consecutive vaccination seasons.ClinicalTrials.gov registration: NCT06030726 .


 
Back
Top Bottom